This House resolution expresses support for designating September 9 as National African Immigrant and Refugee HIV/AIDS and Hepatitis Awareness Day. It highlights that this specific community faces significantly higher rates of HIV and chronic hepatitis B compared to the general U.S. population, often due to barriers such as language differences, stigma, and limited access to culturally appropriate care. The bill encourages increased attention and resources for screening, vaccination, and treatment within these communities to reduce new infections and related deaths.
This House resolution formally recognizes suicide as a significant public health issue in the United States and highlights the impact of the 988 Suicide and Crisis Lifeline on individuals and communities. It commends the establishment of the 988 number as a nationwide three-digit dialing code for crisis support, noting its role in connecting people to mental health resources. The bill supports the designation of September 8, 2026, as "988 Day" to raise awareness about the service and promote access to mental health care. Additionally, it encourages continued public education and federal, state, and local efforts to expand crisis intervention programs for high-risk populations.
The Equity in STI Testing Act requires Medicare Advantage, Medicaid, CHIP, TRICARE, and the Department of Veterans Affairs to cover screening tests for HIV, gonorrhea, syphilis, trichomoniasis, and chlamydia without charging beneficiaries any out-of-pocket costs. The bill directly affects patients enrolled in these federal health programs by eliminating copayments and deductibles specifically for these preventive screenings. It also mandates that the Indian Health Service provide these tests to eligible Native Americans at no cost, regardless of whether the services are typically authorized under their purchased or referred care systems. These changes take effect on different timelines depending on the specific program, with some provisions applying immediately upon enactment and others starting in the following calendar year.
The EBOLA Act requires the President to rejoin the World Health Organization within 30 days of enactment and immediately coordinate with that body to address an ongoing Ebola outbreak in Central and Eastern Africa. The legislation authorizes necessary funding to cover U.S. membership fees and financial obligations, as well as voluntary contributions to support international disease response efforts. By mandating this rapid re-entry into the global health agency, the bill aims to enhance the nation's ability to monitor emerging infectious diseases and prevent the spread of the virus to American soil.
The Health Equity and Accountability Act of 2026 is a comprehensive legislative proposal designed to reduce health disparities by mandating standardized data collection on race, ethnicity, gender identity, and socioeconomic status across federal health programs. The bill requires the Department of Health and Human Services to establish new commissions and task forces focused on preventing bias in artificial intelligence and ensuring equitable data reporting during public health emergencies. It also expands access to care for underserved populations by removing citizenship barriers to Medicaid, increasing funding for minority-serving institutions, and requiring culturally and linguistically appropriate services from federally assisted health providers. Additionally, the legislation addresses specific disease disparities through targeted research grants and mandates that drug manufacturers investigate and report on racial or ethnic differences in drug safety and effectiveness.
This House resolution formally recognizes suicide as a serious public health problem in the United States and expresses support for designating September 2026 as National Suicide Prevention Month and September 10, 2026, as World Suicide Prevention Day. The bill cites data from the CDC, SAMHSA, and the VA to highlight that suicide is a leading cause of death among young people, veterans, and during the postpartum period, while also noting the significant economic costs associated with it. It declares suicide prevention a national priority and emphasizes that mental health is as important as physical health. The resolution supports the development of strategies to improve access to quality mental health, substance abuse, and suicide prevention services for all communities.
The SPF Act of 2026 requires the Director of the National Park Service to submit a report to Congress within one year detailing options for providing free or low-cost mineral-based sunscreen and other sun protection items to park visitors. The bill cites rising skin cancer rates and public health data to support the need for better access to protective measures in national parks. The required report must evaluate potential environmental impacts, ensure products are usable for all skin tones, and propose strategies for increasing visitor awareness about sun safety. Additionally, the report must include specific legislative recommendations for Congress to consider when supporting these efforts.
The SMASH 2.0 Act reauthorizes the federal mosquito abatement program through fiscal year 2030, maintaining annual funding at $100 million for state and local public health agencies. The bill allows the Secretary of Health and Human Services to consider innovative technologies when awarding grants for mosquito prevention and control. It also permits grant recipients to use up to 5 percent of their funds for staff training and continuing education. Additionally, the legislation directs the Department of Health and Human Services to prepare emergency stockpiles of vector-borne disease control products in coordination with the Strategic National Stockpile.
The Launching with Healthcare Act extends the period during which young adults must be covered under their parents' health insurance plans from age 26 to age 31. This change directly affects individuals up to age 31 and the employers or insurers providing these family coverage plans. The bill amends the Public Health Service Act to implement this new age limit, with the provision taking effect for plan years that begin after December 31, 2026.
The Fair Prescription Pricing Act of 2026 would cap the out-of-pocket costs that individuals pay for prescription drugs by limiting deductibles, copayments, and coinsurance to no more than the nationwide average consumer price for that specific medication. This provision applies to both group health plans and individual health insurance policies, ensuring that patients using in-network pharmacies do not face charges higher than the standard market rate. The bill requires pharmacy benefit managers to adhere to these same cost-sharing limits as the insurance providers themselves. These restrictions would be implemented across federal laws governing public health services, employee retirement income security, and internal revenue codes to ensure consistent enforcement for plan years beginning after the act's enactment.
